---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-24-000019"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:57:15.534751+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CVS shareholders approve 33.5M share increase to equity plan; all directors elected

## Summary
- Shareholders approved amendment to 2017 ICP, increasing authorized shares by 33.5 million for future awards.
- All 12 director nominees elected, including CEO Karen S. Lynch, with >85% support from votes cast.
- Advisory vote on named executive officer compensation passed (818M for, 139M against, excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for 2024 approved (1.083B for, 22.9M against).
- Four stockholder proposals (worker rights, majority vote, golden parachute, director time disclosure) all rejected.

## SEC filing metadata
- accession: 0000064803-24-000019
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480324000019/0000064803-24-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480324000019/cvs-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-24-000019
- JSON: https://secwatch.observer/filing/0000064803-24-000019.json
- Plain text: https://secwatch.observer/filing/0000064803-24-000019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.